Transcend Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.32M | Sell |
5,731
-1,486
| -21% | -$602K | 0.18% | 128 |
|
|
2025
Q1 | $3.59M | Sell |
7,217
-157
| -2% | -$78.1K | 0.26% | 95 |
|
|
2024
Q4 | $3.84M | Sell |
7,374
-291
| -4% | -$151K | 0.28% | 90 |
|
|
2024
Q3 | $4.74M | Sell |
7,665
-166
| -2% | -$103K | 0.32% | 74 |
|
|
2024
Q2 | $4.33M | Buy |
7,831
+268
| +4% | +$148K | 0.31% | 70 |
|
|
2024
Q1 | $4.4M | Sell |
7,563
-23
| -0.3% | -$13.4K | 0.35% | 65 |
|
|
2023
Q4 | $4.03M | Buy |
7,586
+188
| +3% | +$99.8K | 0.36% | 63 |
|
|
2023
Q3 | $3.74M | Buy |
7,398
+830
| +13% | +$420K | 0.37% | 62 |
|
|
2023
Q2 | $3.43M | Buy |
6,568
+172
| +3% | +$89.7K | 0.33% | 71 |
|
|
2023
Q1 | $3.69M | Sell |
6,396
-456
| -7% | -$263K | 0.38% | 56 |
|
|
2022
Q4 | $3.77M | Sell |
6,852
-239
| -3% | -$132K | 0.41% | 52 |
|
|
2022
Q3 | $3.6M | Buy |
7,091
+131
| +2% | +$66.5K | 0.4% | 52 |
|
|
2022
Q2 | $3.78M | Buy |
6,960
+382
| +6% | +$208K | 0.39% | 54 |
|
|
2022
Q1 | $3.89M | Buy |
6,578
+16
| +0.2% | +$9.45K | 0.35% | 68 |
|
|
2021
Q4 | $4.38M | Buy |
6,562
+441
| +7% | +$294K | 0.39% | 62 |
|
|
2021
Q3 | $3.72M | Buy |
6,121
+50
| +0.8% | +$30.4K | 0.33% | 74 |
|
|
2021
Q2 | $3.07M | Buy |
6,071
+239
| +4% | +$121K | 0.44% | 61 |
|
|
2021
Q1 | $2.66M | Buy |
5,832
+6
| +0.1% | +$2.74K | 0.32% | 81 |
|
|
2020
Q4 | $2.71M | Buy |
5,826
+427
| +8% | +$199K | 0.36% | 76 |
|
|
2020
Q3 | $2.38M | Buy |
+5,399
| New | +$2.38M | 0.43% | 58 |
|
|
2020
Q2 | – | Sell |
-5,004
| Closed | -$1.42M | – | 194 |
|
|
2020
Q1 | $1.42M | Sell |
5,004
-48
| -1% | -$13.6K | 0.43% | 70 |
|
|
2019
Q4 | $1.64M | Buy |
+5,052
| New | +$1.64M | 0.44% | 72 |
|